Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak

Share this page:

Title

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak

Subject

Description

After the first pandemic wave in Europe, seroprevalence surveys revealed that roughly one in ten individuals had been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Date Last Updated (Year-Month-Day)

2021-02-01

Citation

Stringhini, Silvia, María-Eugenia Zaballa, Javier Perez-Saez, Nick Pullen, Carlos de Mestral, Attilio Picazio, Francesco Pennacchio, Ania Wisniak, Aude Richard, Helene Baysson, Andrea Loizeau, Jean-François Balavoine, Didier Trono, Didier Pittet, Klara Posfay-Barbe, Antoine Flahault, François Chappuis, Omar Kherad, Nicolas Vuilleumier, Laurent Kaiser, Andrew S. Azman, and Idris Guessous. 2021. "Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak." The Lancet Infectious Diseases.

Accessibility

Free online on Lancet site.